Title: SAT-338 THE DILEMMA OF INDUCTION IMMUNOSUPPRESSION IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS- A PROSPECTIVE RANDOMISED STUDY FROM EASTERN INDIA COMPARING BASILIXIMAB VERSUS NO INDUCTION IMMUNOSUPPRESSION
Abstract: Induction immunosuppression decreases the risk for acute rejection and improves graft outcomes in kidney transplant recipients but in the current era of powerful maintenance immunosuppression, role of induction immunosuppression in low immunological risk group of patients is controversial. Hence, this was a suitable research question which was explored by us in an Indian setting. The objective of our study was to evaluate the impact of induction with basiliximab versus no induction therapy on outcomes in low immunological risk kidney transplant recipients (KTRs).